substance p has been researched along with Ophthalmoplegia, Progressive Supranuclear in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Landwehrmeyer, B; Palacios, JM | 1 |
| Agid, Y; Benoliel, JJ; Cesselin, F; Hamon, M; Javoy-Agid, F; Legrand, JC; Mauborgne, A; Taquet, H | 1 |
2 other study(ies) available for substance p and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
Alterations of neurotransmitter receptors and neurotransmitter transporters in progressive supranuclear palsy.
Topics: Aged; Biological Transport; Carrier Proteins; Dopamine; Female; Humans; Male; Neurotransmitter Agents; Radioligand Assay; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA-A; Receptors, Muscarinic; Receptors, Neurotensin; Receptors, Neurotransmitter; RNA, Messenger; Substance P; Supranuclear Palsy, Progressive | 1994 |
Brain neuropeptides in progressive supranuclear palsy.
Topics: Aged; Brain; Cholecystokinin; Corpus Striatum; Dopamine; Enkephalin, Leucine; Enkephalin, Methionine; Humans; Neuropeptides; Substance P; Substantia Nigra; Supranuclear Palsy, Progressive | 1987 |